Zynex (ZYXI) Competitors $7.43 +0.01 (+0.13%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZYXI vs. BBNX, EMBC, BVS, AXGN, CBLL, AVNS, IRMD, SIBN, TMCI, and KIDSShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Beta Bionics (BBNX), Embecta (EMBC), Bioventus (BVS), AxoGen (AXGN), CeriBell (CBLL), Avanos Medical (AVNS), Iradimed (IRMD), SI-BONE (SIBN), Treace Medical Concepts (TMCI), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Zynex vs. Beta Bionics Embecta Bioventus AxoGen CeriBell Avanos Medical Iradimed SI-BONE Treace Medical Concepts OrthoPediatrics Beta Bionics (NASDAQ:BBNX) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Do institutionals and insiders believe in BBNX or ZYXI? 29.7% of Zynex shares are owned by institutional investors. 52.1% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community favor BBNX or ZYXI? Zynex received 23 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 66.67% of users gave Beta Bionics an outperform vote while only 58.00% of users gave Zynex an outperform vote. CompanyUnderperformOutperformBeta BionicsOutperform Votes666.67% Underperform Votes333.33% ZynexOutperform Votes2958.00% Underperform Votes2142.00% Which has preferable earnings & valuation, BBNX or ZYXI? Zynex has higher revenue and earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$53.03M16.15N/AN/AN/AZynex$193.67M1.23$9.73M$0.1549.93 Is BBNX or ZYXI more profitable? Zynex has a net margin of 2.49% compared to Beta Bionics' net margin of 0.00%. Zynex's return on equity of 13.05% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Zynex 2.49%13.05%3.78% Does the media favor BBNX or ZYXI? In the previous week, Beta Bionics had 37 more articles in the media than Zynex. MarketBeat recorded 39 mentions for Beta Bionics and 2 mentions for Zynex. Beta Bionics' average media sentiment score of 0.47 beat Zynex's score of 0.00 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 3 Very Positive mention(s) 4 Positive mention(s) 19 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Zynex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate BBNX or ZYXI? Beta Bionics currently has a consensus target price of $24.83, indicating a potential upside of 24.23%. Zynex has a consensus target price of $14.00, indicating a potential upside of 86.92%. Given Zynex's stronger consensus rating and higher probable upside, analysts clearly believe Zynex is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryZynex beats Beta Bionics on 9 of the 15 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$232.48M$3.38B$5.80B$8.72BDividend YieldN/A1.62%4.74%3.91%P/E Ratio48.6716.9325.4619.31Price / Sales1.2358.89390.85112.45Price / Cash18.0144.0938.0634.58Price / Book5.513.727.574.50Net Income$9.73M$92.00M$3.18B$246.40M7 Day Performance1.08%2.49%-2.57%-3.58%1 Month Performance-8.55%6.27%-1.94%-3.31%1 Year Performance-45.49%10.83%11.42%7.76% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex2.5357 of 5 stars$7.420.0%$14.00+88.7%-42.1%$236.93M$193.67M49.601,100BBNXBeta BionicsN/A$21.81+0.3%N/AN/A$934.78MN/A0.00294Analyst ForecastAnalyst RevisionNews CoverageEMBCEmbecta4.6028 of 5 stars$14.85-8.0%$23.00+54.9%-4.5%$863.29M$1.11B14.852,100Short Interest ↑BVSBioventus3.1863 of 5 stars$10.41-0.1%$15.00+44.1%+106.2%$844.77M$512.34M-17.071,200AXGNAxoGen1.2124 of 5 stars$18.13-0.1%$18.33+1.1%+86.2%$797.90M$159.01M-56.66450Analyst ForecastNews CoverageCBLLCeriBellN/A$21.44-2.1%$32.60+52.1%N/A$767.98MN/A0.00N/AEarnings ReportAnalyst ForecastNews CoverageAVNSAvanos Medical2.2902 of 5 stars$16.55-0.5%N/A-18.4%$760.64M$673.30M48.683,771Earnings ReportNews CoverageIRMDIradimed4.923 of 5 stars$55.23-0.3%$72.00+30.4%+32.0%$699.76M$65.56M37.83110Ex-DividendSIBNSI-BONE4.2213 of 5 stars$16.39-0.1%$23.00+40.3%-11.6%$687.40M$138.89M-17.82350Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageTMCITreace Medical Concepts0.4259 of 5 stars$10.08flat$9.99-0.9%-32.3%$627.95M$202.86M-10.18250KIDSOrthoPediatrics4.2644 of 5 stars$24.62-1.8%$39.00+58.4%-20.9%$596.30M$148.73M-20.02200 Related Companies and Tools Related Companies Beta Bionics Alternatives Embecta Alternatives Bioventus Alternatives AxoGen Alternatives CeriBell Alternatives Avanos Medical Alternatives Iradimed Alternatives SI-BONE Alternatives Treace Medical Concepts Alternatives OrthoPediatrics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZYXI) was last updated on 2/27/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
